好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Risk Stratification for Progressive Multifocal Leukoencephalopathy (PML) in MS Patients: Role of Prior Immunosuppressant Use, Natalizumab-Treatment Duration, and Anti-JCV Antibody Status
MS and Related Diseases
(-)
248
Authors/Disclosures
Alfred W. Sandrock, MD, PhD (Biogen) No disclosure on file
Christophe Hotermans, MD, PhD (Alexion) No disclosure on file
Sandra R. Richman, MD No disclosure on file
No disclosure on file
Sophia S. Lee, PhD No disclosure on file
No disclosure on file
No disclosure on file
Gary Bloomgren, MD, MBA (Biogen Idec) No disclosure on file
Meena Subramanyam, PhD No disclosure on file
Carmen Bozic, MD (Biogen Idec) No disclosure on file